Breast cancer is the most frequently diagnosed cancer in women worldwide. Although dramatically increased survival rates of early diagnosed cases have been observed, late diagnosed patients and metastatic cancer may still be considered fatal. The present study's main focus was on cancer‑associated fibroblasts (CAFs) which is an active component of the tumor microenvironment (TME) regulating the breast cancer ecosystem. Transcriptomic profiling and analysis of CAFs isolated from breast cancer skin metastasis, cutaneous basal cell carcinoma, and squamous cell carcinoma unravelled major gene candidates such as IL6, VEGFA and MFGE8 that induced co‑expression of keratins‑8/‑14 in the EM‑G3 cell line derived from infiltrating ductal breast carcinoma. Western blot analysis of selected keratins (keratin‑8, ‑14, ‑18, ‑19) and epithelial‑mesenchymal transition‑associated markers (SLUG, SNAIL, ZEB1, E‑/N‑cadherin, vimentin) revealed specific responses pointing to certain heterogeneity of the studied CAF populations. Experimental in vitro treatment using neutralizing antibodies against IL-6, VEGF‑A and MFGE8 attenuated the modulatory effect of CAFs on EM‑G3 cells. The present study provided novel data in characterizing and understanding the interactions between CAFs and EM‑G3 cells in vitro. CAFs of different origins support the pro‑inflammatory microenvironment and influence the biology of breast cancer cells. This observation potentially holds significant interest for the development of novel, clinically relevant approaches targeting the TME in breast cancer. Furthermore, its implications extend beyond breast cancer and have the potential to impact a wide range of other cancer types.

Cytogenetic Laboratory Institute of Hematology and Blood Transfusion 128 00 Prague Czech Republic

Department of Pharmacology Faculty of Medicine Pavol Jozef Šafárik University in Košice 040 11 Košice Slovak Republic

Institute of Anatomy 1st Faculty of Medicine Charles University 128 00 Prague Czech Republic

Laboratory of Genomics and Bioinformatics Institute of Molecular Genetics Czech Academy of Sciences 142 20 Prague Czech Republic

See more in PubMed

Ditsch N, Wocke A, Untch M, Jackisch C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, Dall P, et al. AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: Update 2022. Breast Care (Basel) 2022;17:403–420. doi: 10.1159/000524879. PubMed DOI PMC

Garufi G, Carbognin L, Schettini F, Seguí E, Di Leone A, Franco A, Paris I, Scambia G, Tortora G, Fabi A. Updated neoadjuvant treatment landscape for early triple negative breast cancer: Immunotherapy, potential predictive biomarkers, and novel agents. Cancers (Basel) 2022;14:4064. doi: 10.3390/cancers14174064. PubMed DOI PMC

De la Cruz Ku G, Karamchandani M, Chambergo-Michilot D, Narvaez-Rojas AR, Jonczyk M, Príncipe-Meneses FS, Posawatz D, Nardello S, Chatterjee A. Does breast-conserving surgery with radiotherapy have a better survival than mastectomy? A meta-analysis of more than 1,500,000 patients. Ann Surg Oncol. 2022;29:6163–6188. doi: 10.1245/s10434-022-12133-8. PubMed DOI

Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, et al. Cancer survival in five continents: A worldwide population-based study (CONCORD) Lancet Oncol. 2008;9:730–756. doi: 10.1016/S1470-2045(08)70179-7. PubMed DOI

Santoni M, Rizzo A, Kucharz J, Mollica V, Rosellini M, Marchetti A, Tassinari E, Monteiro FSM, Soares A, Molina-Cerrillo J, et al. Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: The MOUSEION-03 meta-analysis. Cancer Immunol Immunother. 2023;72:1365–1379. doi: 10.1007/s00262-022-03349-4. PubMed DOI PMC

Rizzo A, Ricci AD, Lanotte L, Lombardi L, Di Federico A, Brandi G, Gadaleta-Caldarola G. Immune-based combinations for metastatic triple negative breast cancer in clinical trials: Current knowledge and therapeutic prospects. Expert Opin Investig Drugs. 2022;31:557–565. doi: 10.1080/13543784.2022.2009456. PubMed DOI

Rizzo A, Cusmai A, Acquafredda S, Rinaldi L, Palmiotti G. Ladiratuzumab vedotin for metastatic triple negative cancer: Preliminary results, key challenges, and clinical potential. Expert Opin Investig Drugs. 2022;31:495–498. doi: 10.1080/13543784.2022.2042252. PubMed DOI

Hong R, Xu B. Breast cancer: An up-to-date review and future perspectives. Cancer Commun (Lond) 2022;42:913–936. doi: 10.1002/cac2.12358. PubMed DOI PMC

Eliyatkin N, Yalcin E, Zengel B, Aktas S, Vardar E. Molecular classification of breast carcinoma: From traditional, old-fashioned way to a new age, and a new way. J Breast Health. 2015;11:59–66. doi: 10.5152/tjbh.2015.1669. PubMed DOI PMC

Leong AS, Zhuang Z. The changing role of pathology in breast cancer diagnosis and treatment. Pathobiology. 2011;78:99–114. doi: 10.1159/000292644. PubMed DOI PMC

Hanahan D, Weinberg RA. Hallmarks of Cancer: The next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. PubMed DOI

Li JJ, Tsang JY, Tse GM. Tumor microenvironment in breast cancer-updates on therapeutic implications and pathologic assessment. Cancers (Basel) 2021;13:4233. doi: 10.3390/cancers13164233. PubMed DOI PMC

Hatakeyama M, Nozawa H. Hallmarks of Cancer: After the next generation. Cancer Science. 2022;113:885–885. PubMed

Glabman RA, Choyke PL, Sato N. Cancer-Associated Fibroblasts: Tumorigenicity and targeting for cancer therapy. Cancers (Basel) 2022;14:3906. doi: 10.3390/cancers14163906. PubMed DOI PMC

Guo Z, Zhang H, Fu Y, Kuang J, Zhao B, Zhang L, Lin J, Lin S, Wu D, Xie G. Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6. Cell Death Discov. 2023;9:6. doi: 10.1038/s41420-023-01306-3. PubMed DOI PMC

Gal P, Varinska L, Faber L, Novák Š, Szabo P, Mitrengová P, Mirossay A, Mučaji P, Smetana K. How signaling molecules regulate tumor microenvironment: Parallels to wound repair. Molecules. 2017;22:1818. doi: 10.3390/molecules22111818. PubMed DOI PMC

Giorello MB, Borzone FR, Labovsky V, Piccioni FV, Chasseing NA. Cancer-Associated fibroblasts in the breast tumor microenvironment. J Mammary Gland Biol Neoplasia. 2021;26:135–155. doi: 10.1007/s10911-020-09475-y. PubMed DOI

Kolar M, Szabo P, Dvorankova B, Lacina L, Gabius HJ, Strnad H, Sáchová J, Vlček C, Plzák J, Chovanec M, et al. Upregulation of IL-6, IL-8 and CXCL-1 production in dermal fibroblasts by normal/malignant epithelial cells in vitro: Immunohistochemical and transcriptomic analyses. Biol Cell. 2012;104:738–751. doi: 10.1111/boc.201200018. PubMed DOI

Novak S, Kolar M, Szabo A, Vernerová Z, Lacina L, Strnad H, Šáchová J, Hradilová M, Havránek J, Španko M, et al. Desmoplastic crosstalk in pancreatic ductal adenocarcinoma is reflected by different responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 cell lines to cancer-associated/normal fibroblasts. Cancer Genomics Proteomics. 2021;18:221–243. doi: 10.21873/cgp.20254. PubMed DOI PMC

Perzel'ova V, Varinska L, Dvorankova B, Szabo P, Spurný P, Valach J, Mojžiš J, André S, Gabius HJ, Smetana K, Jr, Gál P. Extracellular matrix of galectin-1-exposed dermal and tumor-associated fibroblasts favors growth of human umbilical vein endothelial cells in vitro: A short report. Anticancer Res. 2014;34:3991–3996. PubMed

Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hunter T, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174–186. doi: 10.1038/s41568-019-0238-1. PubMed DOI PMC

Dvorankova B, Szabo P, Lacina L, Kodet O, Matouskova E, Smetana K., Jr Fibroblasts prepared from different types of malignant tumors stimulate expression of luminal marker keratin 8 in the EM-G3 breast cancer cell line. Histochem Cell Biol. 2012;137:679–685. doi: 10.1007/s00418-012-0918-3. PubMed DOI

Brozova M, Kleibl Z, Netikova I, Sevcik J, Scholzova E, Brezinova J, Chaloupkova A, Vesely P, Dundr P, Zadinova M, et al. Establishment, growth and in vivo differentiation of a new clonal human cell line, EM-G3, derived from breast cancer progenitors. Breast Cancer Res Treat. 2007;103:247–257. doi: 10.1007/s10549-006-9358-x. PubMed DOI

Zhao L, Zhao HY, Yan H. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes. BMC Cancer. 2018;18:603. doi: 10.1186/s12885-018-4546-8. PubMed DOI PMC

Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA. 2004;101:811–816. doi: 10.1073/pnas.0304146101. PubMed DOI PMC

Aure MR, Vitelli V, Jernstrom S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Lüders T, et al. Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome. Breast Cancer Res. 2017;19:44. doi: 10.1186/s13058-017-0812-y. PubMed DOI PMC

Strnad H, Lacina L, Kolar M, Cada Z, Vlcek C, Dvoránková B, Betka J, Plzák J, Chovanec M, Sáchová J, et al. Head and neck squamous cancer stromal fibroblasts produce growth factors influencing phenotype of normal human keratinocytes. Histochem Cell Biol. 2010;133:201–211. doi: 10.1007/s00418-009-0661-6. PubMed DOI

Szabo P, Kolar M, Dvorankova B, Lacina L, Štork J, Vlček Č, Strnad H, Tvrdek M, Smetana K., Jr Mouse 3T3 fibroblasts under the influence of fibroblasts isolated from stroma of human basal cell carcinoma acquire properties of multipotent stem cells. Biol Cell. 2011;103:233–248. doi: 10.1042/BC20100113. PubMed DOI

Dvorankova B, Lacina L, Smetana K., Jr Isolation of normal fibroblasts and their cancer-associated counterparts (CAFs) for biomedical research. Methods Mol Biol. 2019;1879:393–406. doi: 10.1007/7651_2018_137. PubMed DOI

Selicharova I, Smutna K, Sanda M, Ubik K, Matousková E, Bursíková E, Brozová M, Vydra J, Jirácek J. 2-DE analysis of a new human cell line EM-G3 derived from breast cancer progenitor cells and comparison with normal mammary epithelial cells. Proteomics. 2007;7:1549–1559. doi: 10.1002/pmic.200600907. PubMed DOI

Mladkova J, Sanda M, Matouskova E, Selicharova I. Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins. BMC Cancer. 2010;10:449. doi: 10.1186/1471-2407-10-449. PubMed DOI PMC

Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes-formation of keratinizing colonies from single cells. Cell. 1975;6:331–344. doi: 10.1016/S0092-8674(75)80001-8. PubMed DOI

Xu M, Zhang T, Xia R, Wei Y, Wei X. Targeting the tumor stroma for cancer therapy. Mol Cancer. 2022;21:208. doi: 10.1186/s12943-022-01670-1. PubMed DOI PMC

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. doi: 10.1093/nar/gkv007. PubMed DOI PMC

Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, Lachmann A, Wojciechowicz ML, Kropiwnicki E, Jagodnik KM, et al. Gene set knowledge discovery with enrichr. Curr Protoc. 2021;1:e90. doi: 10.1002/cpz1.90. PubMed DOI PMC

Athar A, Fullgrabe A, George N, Iqbal H, Huerta L, Ali A, Snow C, Fonseca NA, Petryszak R, Papatheodorou I, et al. ArrayExpress update-from bulk to single-cell expression data. Nucleic Acids Res. 2019;47((D1)):D711–D715. doi: 10.1093/nar/gky964. PubMed DOI PMC

Wang YT, Kuo LT, Weng HH, Hsu CM, Tsai MS, Chang GH, Lee YC, Huang EI, Tsai YT. Systemic Immun e-inflammation index as a predictor for head and neck cancer prognosis: A meta-analysis. Front Oncol. 2022;12:899518. doi: 10.3389/fonc.2022.899518. PubMed DOI PMC

Setiawan T, Sari IN, Wijaya YT, Julianto NM, Muhammad JA, Lee H, Chae JH, Kwon HY. Cancer cachexia: Molecular mechanisms and treatment strategies. J Hematol Oncol. 2023;16:54. doi: 10.1186/s13045-023-01454-0. PubMed DOI PMC

Hanley CJ, Thomas GJ. Targeting cancer associated fibroblasts to enhance immunotherapy: Emerging strategies and future perspectives. Oncotarget. 2021;12:1427–1433. doi: 10.18632/oncotarget.27936. PubMed DOI PMC

Villadsen R, Fridriksdottir AJ, Ronnov-Jessen L, Gudjonsson T, Rank F, LaBarge MA, Bissell MJ, Petersen OW. Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol. 2007;177:87–101. doi: 10.1083/jcb.200611114. PubMed DOI PMC

Romano V, Ruocco MR, Carotenuto P, Barbato A, Venuta A, Acampora V, De Lella S, Vigliar E, Iaccarino A, Troncone G, et al. Generation and Characterization of a tumor stromal microenvironment and analysis of its interplay with breast cancer cells: An in vitro model to study breast cancer-associated fibroblast inactivation. Int J Mol Sci. 2022;23:6875. doi: 10.3390/ijms23126875. PubMed DOI PMC

Ao Z, Shah SH, Machlin LM, Parajuli R, Miller PC, Rawal S, Williams AJ, Cote RJ, Lippman ME, Datar RH, El-Ashry D. Identification of cancer-associated fibroblasts in circulating blood from patients with metastatic breast cancer. Cancer Res. 2015;75:4681–4687. doi: 10.1158/0008-5472.CAN-15-1633. PubMed DOI

Iyer SV, Dange PP, Alam H, Sawant SS, Ingle AD, Borges AM, Shirsat NV, Dalal SN, Vaidya MM. Understanding the role of keratins 8 and 18 in neoplastic potential of breast cancer derived cell lines. PLoS One. 2013;8:e53532. doi: 10.1371/journal.pone.0053532. PubMed DOI PMC

Hanley CJ, Henriet E, Sirka OK, Thomas GJ, Ewald AJ. Tumor-Resident Stromal cells promote breast cancer invasion through regulation of the basal phenotype. Mol Cancer Res. 2020;18:1615–1622. doi: 10.1158/1541-7786.MCR-20-0334. PubMed DOI PMC

Cheung KJ, Gabrielson E, Werb Z, Ewald AJ. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell. 2013;155:1639–1651. doi: 10.1016/j.cell.2013.11.029. PubMed DOI PMC

Cserni G, Francz M, Jaray B, Kálmán E, Kovács I, Krenács T, Tóth E, Udvarhelyi N, Vass L, Vörös A, et al. Pathological diagnosis, work-up and reporting of breast cancer 1st central-eastern european professional consensus statement on breast cancer. Pathol Oncol Res. 2022;28:1610373. doi: 10.3389/pore.2022.1610373. PubMed DOI PMC

Wang X, Ji S, Ma Y, Xing X, Zhou Y, Xu X, Song J, Wang S, Jiang W, Wang X, et al. Vimentin plays an important role in the promotion of breast cancer cell migration and invasion by leucine aminopeptidase 3. Cytotechnology. 2020;72:639–647. doi: 10.1007/s10616-020-00402-x. PubMed DOI PMC

Chen MH, Yip GW, Tse GM, Moriya T, Lui PC, Zin ML, Bay BH, Tan PH. Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters. Mod Pathol. 2008;21:1183–1191. doi: 10.1038/modpathol.2008.90. PubMed DOI

Yamashita N, Tokunaga E, Kitao H, Hisamatsu Y, Taketani K, Akiyoshi S, Okada S, Aishima S, Morita M, Maehara Y. Vimentin as a poor prognostic factor for triple-negative breast cancer. J Cancer Res Clin Oncol. 2013;139:739–746. doi: 10.1007/s00432-013-1376-6. PubMed DOI PMC

Zhang Z, Fang T, Lv Y. Prognostic and clinicopathological value of Slug protein expression in breast cancer: A systematic review and meta-analysis. World J Surg Oncol. 2022;20:361. doi: 10.1186/s12957-022-02813-w. PubMed DOI PMC

Soini Y, Tuhkanen H, Sironen R, Virtanen I, Kataja V, Auvinen P, Mannermaa A, Kosma VM. Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer. 2011;11:73. doi: 10.1186/1471-2407-11-73. PubMed DOI PMC

Horne HN, Oh H, Sherman ME, Palakal M, Hewitt SM, Schmidt MK, Milne RL, Hardisson D, Benitez J, Blomqvist C, et al. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. Sci Rep. 2018;8:6574. doi: 10.1038/s41598-018-23733-4. PubMed DOI PMC

Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000;148:779–790. doi: 10.1083/jcb.148.4.779. PubMed DOI PMC

Brock T, Boudriot E, Klawitter A, Großer M, Nguyen TTP, Giebe S, Klapproth E, Temme A, El-Armouche A, Breier G. The Influence of VE-Cadherin on adhesion and incorporation of breast cancer cells into vascular endothelium. Int J Mol Sci. 2021;22:6049. doi: 10.3390/ijms22116049. PubMed DOI PMC

Kieffer Y, Hocine HR, Gentric G, Pelon F, Bernard C, Bourachot B, Lameiras S, Albergante L, Bonneau C, Guyard A, et al. Single-Cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. Cancer Discov. 2020;10:1330–1351. doi: 10.1158/2159-8290.CD-19-1384. PubMed DOI

Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FP, van Riel JM, Peters NA, et al. Prognosis of metastatic breast cancer: Are there differences between patients with de novo and recurrent metastatic breast cancer? Br J Cancer. 2015;112:1445–1451. doi: 10.1038/bjc.2015.127. PubMed DOI PMC

Wound healing: insights into autoimmunity, ageing, and cancer ecosystems through inflammation and IL-6 modulation